Betaseron news from FiercePharma
NewsSwiss pricing pressure angers Vasella
Daniel Vasella (photo) is riled. The Novartis CEO says its hometown officials are putting too much pressure on drug Read more...
| Press ReleasesPRESS RELEASE: Novartis Completes Agreement With Bayer Schering Related To Betaseron Rights And Manufacturing Novartis Completes Agreement With Bayer Schering Related To Betaseron® Rights And Manufacturing Basel, Switzerland, Sept 14, 2007 - Basel, September 14, 2007 - Novartis has completed an agreement Read more... |
Get more Betaseron coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets